Delivery Order SPE2DB20D3303-SPE2DB25FY8F1
Award Date
1/13/25
Potential Completion Date
1/14/25
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $2,477.49, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medical product, with a completion date of January 8, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds...
This federal contract award, with an ID of SPE2DB22D2211|SPE2DB25FRSMN, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medical product, with a ceiling value of $20,908.16 and a period of performance through March 4, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,669.00, is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medical product. It is a delivery order contract with a firm fixed price. The contract has an ultimate completion date of November 29, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a medical product. The contract has a ceiling value of $2,176.72 and is a Firm Fixed Price Delivery Order. It does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The fixed-price delivery order has a ceiling value of $4,753.75 and an ultimate completion date of February 27, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $9,649.93, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of January 30, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award, identified as SPE2DB20D1100|SPE2DB25FA3X3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,533.16 firm fixed-price delivery order is for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a medical product. The contract has a period of performance through February 3, 2025 and does not include a set-aside designation, indicating open competition. Amerisourcebergen...
This federal contract award, valued at $3,834.93, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a specialty medication, with an ultimate completion date of October 30, 2024. This is a firm fixed-price delivery order contract, and there is no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,208.18, is for the delivery of MOUNJARO 10 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of March 22, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MOUNJARO 10 MG/0.5 ML PEN 0.5ML. The contract has a ceiling value of $1,632.54 and runs through February 6, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued...